John Brew

This inventor holds 65 USPTO granted patents and 18 published patent applications, plus 5 CIPO patents and 11 EPO patents, primarily in Chronic Inflammation (CPC class A61K). Top assignees: Infirst Healthcare Limited, Biocopea Limited, Health Clinics Limited. Active years: 2011-2026.

USPTO Granted Patents = 65 (Patent Applications = 18)

% Patents Active = 90.8

CIPO Patents = 5 (Patent Applications = 15)

EPO Patents = 11 (Patent Applications = 33)

Average Co-Inventor Count = 3.4

ph-index = 20

Forward Citations = 957(Granted Patents)

Forward Citations (Not Self Cited) = 111(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Saffron Walden, GB (2011)
Essex, GB (2012)
London, GB (2014 - 2019)
Hertfordshire, GB (2014 - 2023)
St. Albans, GB (2023 - 2024)

Company Filing History:

54 out of 54

Infirst Healthcare Limited

Health Clinics Limited

patents

4. 2 out of 2

Trx Biosciences Limited

patents

5. 1 out of 1

Infirst Helathcare Limited

patent

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

Chronic Inflammation

Bioavailability

Pain Management

Cannabidiols

Cardiovascular Disease

NSAIDs

Drug Combinations

Therapeutics

Cancer Treatments

Solid Solution Compositions

Oral Suspensions

Inflammatory Diseases

65 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12685709 - Solid solution compositions and use in chronic inflammation (2026-07-21),

2. 12678502 - Compositions having improved bioavailability of therapeutics (2026-07-14),

3. 12533332 - Compositions and methods for treating chronic inflammation and inflammatory diseases (2026-01-27),

4. 12226484 - Compositions having improved bioavailability of therapeutics (2025-02-18),

5. 11992555 - Solid solution compositions and use in chronic inflammation (2024-05-28),

6. 11918654 - Solid solution compositions and use in severe pain (2024-03-05),

7. 11844773 - Solid solution compositions and use in chronic inflammation (2023-12-19),

8. 11826428 - Solid solution compositions comprising cannabidiols (2023-11-28),

9. 11730709 - Compositions and methods for treating severe pain (2023-08-22),

10. 11660276 - Compositions and methods for treating chronic inflammation and inflammatory diseases (2023-05-30),

11. 11224659 - Solid solution compositions and use in severe pain (2022-01-18),

12. 11202831 - Solid solution compositions and use in cardiovascular disease (2021-12-21),

13. 11154500 - Solid solution compositions and use in chronic inflammation (2021-10-26),

14. 11103472 - Oral suspensions comprising a non-steroidal anti-inflammatory drug (NSAID) (2021-08-31),

15. 11065218 - Compositions and methods for treating chronic inflammation and inflammatory diseases (2021-07-20),

Title: The Innovative Mind of John Brew

Introduction: John Brew, a pioneering inventor hailing from Hertfordshire, GB, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: John Brew's recent patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience, as well as a sustainable energy solution aimed at reducing carbon emissions.

Career Highlights: With a career spanning over two decades, John Brew has consistently pushed the boundaries of technological advancement. His work has been instrumental in shaping the future of various industries, from healthcare to renewable energy.

Collaborations: Throughout his career, John Brew has collaborated with leading research institutions, universities, and tech companies to bring his innovative ideas to life. His ability to work seamlessly in multidisciplinary teams has led to the development of cutting-edge solutions.

Conclusion: John Brew's passion for innovation, coupled with his relentless drive to create a positive impact on society, solidifies his position as a trailblazing inventor in the realm of technology. His continued dedication to pushing the boundaries of what is possible ensures that his legacy will endure for generations to come.